Published in Neurology on August 28, 2007
Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain (2013) 1.02
Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord (2010) 1.02
Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain (2014) 0.95
Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology (2016) 0.93
Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. J Headache Pain (2015) 0.82
Cuneus and fusiform cortices thickness is reduced in trigeminal neuralgia. J Headache Pain (2014) 0.80
The role of sensory fiber demography in trigeminal and postherpetic neuralgias. J Dent Res (2011) 0.80
Is chronic migraine a primary or a secondary condition? Neurol Sci (2010) 0.80
Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci (2008) 0.79
Trigeminal neuralgia. BMJ Clin Evid (2014) 0.79
Evaluation of the pathophysiology of classical trigeminal neuralgia by blink reflex study and current perception threshold testing. J Headache Pain (2010) 0.78
Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial. Trials (2015) 0.78
[Clinical application of pain-related evoked potentials]. Schmerz (2012) 0.78
From paroxysmal to chronic pain in trigeminal neuralgia: implications of central sensitization. Neurology (2007) 0.77
Altered regional homogeneity of spontaneous brain activity in idiopathic trigeminal neuralgia. Neuropsychiatr Dis Treat (2015) 0.77
[Orofacial pain - Trigeminal neuralgia and posttraumatic trigeminal neuropathy : Common features and differences]. Schmerz (2016) 0.75
Diagnostic value of some less frequently considered blink reflex parameters in idiopathic trigeminal neuralgia. Wien Klin Wochenschr (2011) 0.75
The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia (2007) 10.90
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
European principles of management of common headache disorders in primary care. J Headache Pain (2007) 4.77
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Brain stem activation in spontaneous human migraine attacks. Nat Med (1995) 2.67
The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol (2011) 2.53
Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology (2009) 2.40
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Practical experiences on the necessity of external validation. Stat Med (2007) 2.09
Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract (2005) 2.01
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci U S A (2008) 1.97
Features of medication overuse headache following overuse of different acute headache drugs. Neurology (2002) 1.93
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia (2012) 1.63
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain (2005) 1.59
Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology (2010) 1.58
Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia (2007) 1.56
The burden of headache in Russia: validation of the diagnostic questionnaire in a population-based sample. Eur J Neurol (2010) 1.55
Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia (2007) 1.52
Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology (2004) 1.44
Incidence and predictors of chronic headache attributed to whiplash injury. Cephalalgia (2010) 1.43
Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine. Cephalalgia (2006) 1.43
[Recent new information on epidemiology of headache]. Fortschr Neurol Psychiatr (2004) 1.42
Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry (2005) 1.34
Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis (2009) 1.34
Migraine with isolated facial pain: a diagnostic challenge. Cephalalgia (2007) 1.34
The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia (2012) 1.30
The human cerebellum contributes to motor, emotional and cognitive associative learning. A review. Cortex (2009) 1.29
Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol (2002) 1.28
Patient-centered yes/no prognosis using learning machines. Int J Data Min Bioinform (2008) 1.26
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol (2004) 1.24
Structural gray and white matter changes in patients with HIV. J Neurol (2011) 1.22
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain (2012) 1.19
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol (2008) 1.19
Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain (2012) 1.18
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
A new method to increase nociception specificity of the human blink reflex. Clin Neurophysiol (2000) 1.17
Comparison of eyeblink conditioning in patients with superior and posterior inferior cerebellar lesions. Brain (2003) 1.14
Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia (2006) 1.11
Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia (2007) 1.07
Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery. J Neurol (1999) 1.07
Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia (2007) 1.07
The Eurolight project: the impact of primary headache disorders in Europe. Description of methods. J Headache Pain (2011) 1.06
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol (2009) 1.06
Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia (2006) 1.06
Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry (2005) 1.05
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain (1996) 1.05
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. Acta Neurol Scand (2013) 1.04
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol (2002) 1.04
Probabilistic 3D MRI atlas of the human cerebellar dentate/interposed nuclei. Neuroimage (2005) 1.04
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol (2003) 1.03
Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry (1999) 1.01
Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia (2006) 1.01
MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology (2000) 1.01
Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology (2002) 1.01
Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res (1992) 0.99
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opin Pharmacother (2009) 0.99
Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache (2007) 0.99
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain (1996) 0.98
Gray matter changes related to chronic posttraumatic headache. Neurology (2009) 0.98
Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol (2014) 0.98
G protein beta3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther (2007) 0.98
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol (2004) 0.97
Prosopagnosia as symptom of migraine with aura: a case report. Cephalalgia (2006) 0.96
A practical guide to the management and prevention of migraine. Drugs (1998) 0.96
Evolution of purely infratentorial PML under HAART--negative outcome under rapid immune reconstitution. Clin Neurol Neurosurg (2004) 0.96
Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation. Eur Neurol (2008) 0.96
Sumatriptan. BMJ (1994) 0.96
Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain (2004) 0.95
Experimental cranial pain elicited by capsaicin: a PET study. Pain (1998) 0.95
Occipital nerve stimulation for the treatment of chronic cluster headache - lessons learned from 18 months experience. Cent Eur Neurosurg (2011) 0.94
Acetylsalicylic acid in the treatment of headache. Cephalalgia (1999) 0.94
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses. J Neural Transm (Vienna) (2010) 0.94
Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia. Eur J Neurol (2008) 0.93
Abnormal habituation of 'nociceptive' blink reflex in migraine--evidence for increased excitability of trigeminal nociception. Cephalalgia (2003) 0.93
Diagnostics of cervicogenic headache. Funct Neurol (1990) 0.92
Chronic migraine: classification and comparisons. Cephalalgia (2011) 0.91
What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? J Headache Pain (2011) 0.91
Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis (2011) 0.91
Lateralized central facilitation of trigeminal nociception in cluster headache. Neurology (2012) 0.90